- THIS ARTICLE
- Full Text
- Full Text (PDF)
- Data Supplement
-
All Versions of this Article:
genetics.107.078394v1
178/3/1457 most recent - Alert me when this article is cited
- Alert me if a correction is posted
- SERVICES
- Related articles in Genetics
- Similar articles in this journal
- Similar articles in PubMed
- Alert me to new issues of the journal
- Download to citation manager
- Reprints & Permissions
- CITING ARTICLES
- Citing Articles via Google Scholar
- GOOGLE SCHOLAR
- Articles by Cao, W.
- Articles by Konsolaki, M.
- Search for Related Content
- PUBMED
- PubMed Citation
- Articles by Cao, W.
- Articles by Konsolaki, M.
Originally published as Genetics Published Articles Ahead of Print on February 3, 2008.
Genetics, Vol. 178, 1457-1471, March 2008, Copyright © 2008
doi:10.1534/genetics.107.078394
Identification of Novel Genes That Modify Phenotypes Induced by Alzheimer's β-Amyloid Overexpression in Drosophila
Weihuan Cao*,
Ho-Juhn Song
,
Tina Gangi*,
Anju Kelkar
,
Isha Antani*,
Dan Garza
and
Mary Konsolaki*,1
* Department of Genetics, Rutgers, The State University of New Jersey, Piscataway, New Jersey 08854 and
Novartis Institutes for Biomedical Research, Cambridge, Massachusetts 02139
1 Corresponding author: Department of Genetics, Rutgers, The State University of New Jersey, Piscataway, NJ 08854.
E-mail: konsolaki{at}biology.rutgers.edu
Sustained increases in life expectancy have underscored the importance of managing diseases with a high incidence in late life, such as various neurodegenerative conditions. Alzheimer's disease (AD) is the most common among these, and consequently significant research effort is spent on studying it. Although a lot is known about the pathology of AD and the role of β-amyloid (Aβ) peptides, the complete network of interactions regulating Aβ metabolism and toxicity still eludes us. To address this, we have conducted genetic interaction screens using transgenic Drosophila expressing Aβ and we have identified mutations that affect Aβ metabolism and toxicity. These analyses highlight the involvement of various biochemical processes such as secretion, cholesterol homeostasis, and regulation of chromatin structure and function, among others, in mediating toxic Aβ effects. Several of the mutations that we identified have not been linked to Aβ toxicity before and thus constitute novel potential targets for AD intervention. We additionally tested these mutations for interactions with tau and expanded-polyglutamine overexpression and found a few candidate mutations that may mediate common mechanisms of neurodegeneration. Our data offer insight into the toxicity of Aβ and open new areas for further study into AD pathogenesis
Related articles in Genetics:
ISSUE HIGHLIGHTS
Genetics 2008 178: NP.